Sintx Technologies (SINT) EPS (Basic) Growth (3y) (2018 - 2026)
Sintx Technologies (SINT) EPS (Basic) Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.60 Bn | 197.00 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 126.56 Bn | 123.08 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 119.14 Bn | 109.92 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 74.21 Bn | 73.67 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 51.58 Bn | 47.32 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.93 Bn | 32.98 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 33.73 Bn | 31.62 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.16 Bn | 22.67 Bn | 684.20 Mn | 17.98% |
| 10 | Sintx Technologies | 7.56 Mn | 7.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.84% |
| Dec 31, 2025 | 94.77% |
| Sep 30, 2025 | 88.38% |
| Jun 30, 2025 | 92.34% |
| Mar 31, 2025 | 91.74% |
| Dec 31, 2024 | 89.02% |
| Sep 30, 2024 | 84.58% |
| Jun 30, 2024 | 87.49% |
| Mar 31, 2024 | 72.74% |
| Dec 31, 2023 | 61.11% |
| Sep 30, 2023 | 59.03% |
| Jun 30, 2023 | 74.06% |
| Mar 31, 2023 | 75.62% |
| Dec 31, 2022 | 24.03% |
| Sep 30, 2022 | 49.29% |
| Jun 30, 2022 | 68.61% |
| Mar 31, 2022 | 62.95% |
| Dec 31, 2021 | 86.93% |
| Sep 30, 2021 | 83.93% |
| Jun 30, 2021 | 87.73% |